All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Emerging contaminants (ECs) are mainly substances that many of them are unregulated or inadequately regulated and has raised the public attention to their presence in the environment used by different kinds of aspect, for instance, industrial and domestic \[[@pone.0122813.ref001],[@pone.0122813.ref002]\]. The occurrence and fate of ECs in aquatic environments have been widely studied. Increasing contamination of aquatic systems by ECs is a major problem for aquatic life, as well as for human health, as they are highly mobile and often of toxicological concern \[[@pone.0122813.ref003]--[@pone.0122813.ref006]\]. Pharmaceuticals and personal care products (PPCPs), as well as illicit drugs, are increasingly discharged with wastewater to surface water environments \[[@pone.0122813.ref007]--[@pone.0122813.ref009]\]. Several direct and indirect pathways are available for introduction of ECs into an aqueous environment. One primary route is via effluent from municipal wastewater treatment plants (WWTPs) \[[@pone.0122813.ref010]--[@pone.0122813.ref012]\]. Since wastewater treatment processes are designed primarily to remove pathogens, suspended particles, and nutrients from sewage, removal of ECs is purely incidental and their elimination varies \[[@pone.0122813.ref010],[@pone.0122813.ref013]\]. Several authors have documented conventional wastewater treatment showed inadequate on ECs removal \[[@pone.0122813.ref011],[@pone.0122813.ref014],[@pone.0122813.ref015]\]. Several ECs may be susceptible to degradation or transformation, but their continuous introduction into the aquatic environment in reality confers some degree of pseudo-persistence \[[@pone.0122813.ref010],[@pone.0122813.ref016]\]. Although these compounds occur at relatively low concentrations, their continual long-term release may nevertheless result in significant environmental impacts.

According to statistical data from the Taiwan Food and Drug Administration, drug disposal in Taiwan amounts to 36 tons per year, and total medical expenses in 2011 reached 48 billion US dollars \[[@pone.0122813.ref017]\]. Therefore, the large amounts of unconsumed drugs may be present in the water systems. Available information concerning ECs in Taiwan is still limited. Few recent studies focus on selected sampling locations (industrial and hospital) for certain pharmaceuticals in northern Taiwan \[[@pone.0122813.ref018],[@pone.0122813.ref019]\], while the occurrence of ECs in the water systems of southern Taiwan, particularly any effect on water quality in adjacent areas, remains unknown.

Multivariate statistical techniques, such as receptor model and cluster analysis, have been widely used to apportion the contributions of contaminants derived from different sources and investigate the distribution pattern and association of contaminants in the environment \[[@pone.0122813.ref020],[@pone.0122813.ref021]\]. In addition, taking into account the ubiquity of the selected ECs, the relative abundance of contaminants, as opposed to absolute concentrations, can be considered as a chemical signature specific to a source contribution or contaminant plume. This chemical signature can help to better understand the fate and contribution of ECs in aquatic environments.

This study develops a methodology for a concept we refer to as the "Pharmaco-signature" for a source assessment of ECs in the particular land-use zone with a particular contribution of a mixture of ECs. The methodology is built upon a comprehensive and exploratory multivariate data analysis including the principal component analysis-multiple linear regression model (PCA-MLR) and the hierarchical cluster analysis (HCA). This methodology makes it possible to (a) obtain more information about the structure of the data; and (b) separate and discern the source contributions of ECs. Results of this study could provide information on levels, sources and potential risks of ECs, and for protecting water resources and environmental management in Taiwan.

Materials and Methods {#sec002}
=====================

Ethics Statement {#sec003}
----------------

For sampling in the four rivers of Kaohsiung, no specific permit was required for the described field study. The study location is not privately owned or protected in any way and we confirm that the field study did not involve endangered or protected species.

Materials {#sec004}
---------

The chemicals and standards used (including suppliers, purities, and detailed physicochemical properties of the 28 selected ECs) are described in [S1 Text](#pone.0122813.s002){ref-type="supplementary-material"} and [S1](#pone.0122813.s002){ref-type="supplementary-material"} Table of the Supporting Information.

Study area and sample collection {#sec005}
--------------------------------

The study area covers the entirety of the urban, suburban, animal husbandry, and rural districts of Kaohsiung (22°18' N, 120°38' E), which has a population of 3 million and is also the largest industrial city in Taiwan. A map of the four selected rivers and our sampling locations are shown in [Fig 1](#pone.0122813.g001){ref-type="fig"}. Detailed description and coordinates of the sampling sites is included in the [Table 1](#pone.0122813.t001){ref-type="table"}. Like many other rivers in Taiwan, these four rivers receive a variety of wastewaters from untreated domestic wastewater and/or animal husbandry discharge \[[@pone.0122813.ref022]\]. Gaoping River has the largest drainage basin, including rural, suburban, animal husbandry, and industrial regions of Kaohsiung, with an area of 3,256 km^2^. Gaoping River is also the longest river in Taiwan, with a length of approximately 140 km. Love River flows through the most urbanized and densely populated area of Kaohsiung City, with a length of 16.4 km and a 56 km^2^ drainage area. Houjin River and Dianbao River have drainage basins of 70.4 and 107.1 km^2^ and lengths of 21 and 25 km, respectively. Both rivers drain a partially rural region, with one tributary (located near H2) of the Houjin River flows through a suburban area, and downstream Dianbao River flows through an animal husbandry area. Two sampling campaigns were conducted in April 2010 (dry season) and July 2013 (wet season) at the water systems, with sampling sites denoted as follows: Gaoping River (sites G1-G8), Love River (L1-L10), Houjin River (H1-H4), and Dianbao River (D1-D4). Surface water samples (1L) in duplicate were collected in pre-cleaned amber glass bottles at each sampling site. All of the samples were stored in a cooler during sampling campaigns and were immediately transported to the laboratory.

![Location of the water systems and sampling points in southern Taiwan.\
Sites G1-G8 are located on the Gaoping River. Sites L1-L10 are on the Love River. Sites H1-H4 are on the Houjin River and sites D1-D4 are on the Dianbao River.](pone.0122813.g001){#pone.0122813.g001}

10.1371/journal.pone.0122813.t001

###### Detailed description and coordinates of the sampling sites in the water systems.

![](pone.0122813.t001){#pone.0122813.t001g}

  Site                Latitude    Longitude    Type             Influence                    Note
  ------------------- ----------- ------------ ---------------- ---------------------------- -----------------------------------------
  **Gaoping River**                                                                          
  G1                  N 23.047°   E 120.668°   Fresh water      Rural                        
  G2                  N 22.995°   E 120.638°   Fresh water      Rural                        
  G3                  N 22.885°   E 120.640°   Fresh water      Rural                        
  G4                  N 22.798°   E 120.512°   Fresh water      Rural                        
  G5                  N 22.770°   E 120.451°   Fresh water      Husbandry                    
  G6                  N 22.646°   E 120.437°   Fresh water      Husbandry/Industrial/Urban   
  G7                  N 22.593°   E 120.440°   Fresh water      Husbandry/Industrial/Urban   
  G8                  N 22.498°   E 120.420°   Brackish water   Industrial                   
  **Love River**                                                                             
  L1                  N 22.677°   E 120.322°   Fresh water      Urban                        Kaohsiung Veterans General Hospital
  L2                  N 22.659°   E 120.311°   Fresh water      Urban                        Tributary
  L3                  N 22.653°   E 120.306°   Fresh water      Urban                        Kaohsiung Medical University & Hospital
  L4                  N 22.652°   E 120.296°   Fresh water      Urban                        
  L5                  N 22.650°   E 120.288°   Fresh water      Urban                        
  L6                  N 22.645°   E 120.281°   Fresh water      Urban                        River interception station
  L7                  N 22.640°   E 120.283°   Fresh water      Urban                        
  L8                  N 22.632°   E 120.286°   Fresh water      Urban                        
  L9                  N 22.626°   E 120.288°   Fresh water      Urban                        River interception station
  L10                 N 22.620°   E 120.290°   Brackish water   Urban                        
  **Houjin River**                                                                           
  H1                  N 22.729°   E 120.314°   Fresh water      Rural/Suburban               
  H2                  N 22.724°   E 120.291°   Fresh water      Suburban                     
  H3                  N 22.720°   E 120.281°   Fresh water      Suburban                     
  H4                  N 22.714°   E 120.261°   Brackish water   Suburban                     
  **Dianbao River**                                                                          
  D1                  N 22.752°   E 120.273°   Fresh water      Rural/Industrial             
  D2                  N 22.734°   E 120.264°   Fresh water      Industrial                   
  D3                  N 22.726°   E 120.262°   Fresh water      Husbandry                    
  D4                  N 22.718°   E 120.255°   Brackish water   Husbandry                    

Sample preparation and analysis {#sec006}
-------------------------------

Chemical analysis of ECs followed the methods employed in our previous study \[[@pone.0122813.ref023]\]. Water samples were filtered through 0.7 μm glass fiber filters, then acidified to pH = 6 by adding 0.1 M HCl, followed by addition of 0.2 g/L Na~2~EDTA as the chelating agent. For solid-phase extraction (SPE) of water samples, 300 mL water samples were spiked with acetaminophen-d~4~, amphetamine-d~11~, methamphetamine-d~14~, MDMA-d~5~, ^13^C~6~-ibuprofen, and ^13^C~3~-caffeine as isotopically labelled surrogates in quantifying procedural recovery. An Oasis HLB cartridge (500 mg, 6 mL, Waters, Milfort, USA) was conditioned with 6 mL methanol and 6 mL deionized water. The water sample was then passed through the pre-conditioned SPE-cartridge at a flow rate of approximately 20 mL/min. Then, the cartridge was rinsed with 6 mL deionized (DI) water and dried for 30 min using the vacuum of the SPE manifold. The analyte was then eluted by 6 mL of methanol. The extract was evaporated to dryness under a gentle nitrogen stream. Afterwards, the residue was re-dissolved in a final 1 mL volume with a 50:50 (v/v) solution of methanol in DI water and filtered through a 0.22 μm filter and analyzed by liquid chromatography-tandem mass spectrometry coupled with electrospray ionization (LC-ESI-MS/MS).

Chromatography was performed using an Agilent 1200 module (Agilent Technologies, Palo Alto, CA, USA). The injection volume for PPCPs and illicit drugs was 50 and 10 μL, respectively, and the auto-sampler was operated at room temperature. Separation of PPCPs was performed on a 150 × 4.6 mm ZORBAX Eclipse XDB-C18 column with a 5 μm particle size (Agilent, Palo Alto, CA, USA). Illicit drugs were separated on a Kinetex PFP column (Phenomenex, Torrance, CA, USA, 100 × 2.1 mm, 2.6 μm). The gradients and mass spectrometer conditions used are described in the [S1 Text](#pone.0122813.s004){ref-type="supplementary-material"}.

Method validation and quality control {#sec007}
-------------------------------------

For all the compounds, wide linearity ranges were obtained for the quantification. Seven to ten points' calibration curves were constructed using least-squares linear regression analysis, and subjecting them to the same SPE procedures used for the environmental water samples (river waters) spiked with the analytes, typically from 0.5 to 2000 ng/L with *r* ^2^ \> 0.9991 for all compounds. Recovery experiments were performed on DI water and river water samples spiked with 500 ng/L target analytes and isotopically labelled surrogates to estimate the precision, recovery, and accuracy of the analytical method. [Table 2](#pone.0122813.t002){ref-type="table"} presents the recoveries for the target analytes in DI water and river water. Mean recoveries in DI water range from 74 to 110%, and in river water they range from 76 to 115%. Mean recoveries of the isotopically labelled surrogate standards (acetaminophen-d~4~, amphetamine-d~11~, methamphetamine-d~14~, MDMA-d~5~, ^13^C~6~-ibuprofen and ^13^C~3~-caffeine) are 87 ± 11%, 74 ± 13%, 82 ± 15%, 84 ± 9%, 89 ± 8%, and 93 ± 12%, respectively. Blank samples and duplicate samples are analyzed in each batch to assure quality of the analysis. Analysis of these blanks demonstrated that the extraction and sampling procedures were free of contamination. The relative percentage difference for individual target congeners identified in paired duplicates is less than 10%. The limits of detection (LODs) are defined as three times the standard deviation of the blank samples, and the limits of quantification (LOQs) for the analytes are defined as three times the LODs (International Organization for Standardization, ISO/TS 13530, 2009). The target compound LODs ranged from 0.15 to 1.79 ng/L, and the LOQs ranged from 0.45 to 5.36 ng/L ([Table 2](#pone.0122813.t002){ref-type="table"}). Overall, the validation data, such as repeatability, recoveries, and limits of detection are good, and therefore a reliable determination of the target compounds is feasible.

10.1371/journal.pone.0122813.t002

###### The 28 EC compounds, their MRM pairs, recoveries in deionized (DI) water and river water, and limits of quantification (LOQ).

![](pone.0122813.t002){#pone.0122813.t002g}

  Chemical                                   DF (%)   LOQ (ng/L)   MRM1 (quantification)   MRM2 (confirmation)   Recovery (%) ± SD (n = 3)   
  ------------------------------------------ -------- ------------ ----------------------- --------------------- --------------------------- --------------
  **NSAIDs**                                                                                                                                 
  Acetaminophen                              39.3     3.35         152/110                 152/93                111 ± 11                    115.2 ± 7.4
  Diclofenac                                 82.1     2.80         294/250                 294/214               101.3 ± 6.6                 112.4 ± 9.7
  Ibuprofen                                  100      2.53         205/161                 205/158               87.7 ± 6.5                  95.6 ± 7.3
  Ketoprofen                                 89.3     5.36         252/209                 \-                    89.8 ± 9.7                  87.8 ± 8.3
  Naproxen                                   89.3     1.72         228/169                 228/184               98.6 ± 6.1                  101.2 ± 3.5
  Salicylic acid                             85.7     2.50         136/65                  136/93                99.2 ± 9.3                  105.2 ± 6.4
  Codeine                                    85.7     0.96         300/153                 300/215               103.4 ± 7.3                 104 ± 2.7
  **Antibiotics**                                                                                                                            
  Sulfamethoxazole                           85.7     0.53         254/156                 254/92                105.7 ± 6.2                 103.8 ± 7.0
  Ampicillin                                 75       4.05         350/160                 350/333               93.9 ± 3.9                  107.3 ± 16.2
  Tetracycline                               92.9     5.04         445/154                 445/410               86.2 ± 7.6                  97.3 ± 6.8
  Erythromycin-H~2~O                         82.1     1.07         734/576                 734/158               91.5 ± 4.2                  96.8 ± 4.3
  **Lipid regulator**                                                                                                                        
  Clofibric acid                             39.3     5.32         213/126                 213/91                86.0 ± 3.7                  92.0 ± 3.1
  Gemfibrozil                                78.6     0.51         248/121                 248/126               94.0 ± 8.3                  76.1 ± 8.6
  **Antiepileptic drugs**                                                                                                                    
  Carbamazepine                              82.1     2.15         237/194                 237/179               80.8 ± 9.4                  99.3 ± 8.6
  **Psychostimulants**                                                                                                                       
  Caffeine                                   78.6     0.75         195/138                 195/110               87.4 ± 5.3                  91.2 ± 7.1
  **Ulcer healing**                                                                                                                          
  Omeprazole                                 0        1.02         346/197                 346/179               74.1 ± 1.6                  73.1 ± 6.5
  **Sunscreen agents**                                                                                                                       
  Benzophenone-3                             42.9     5.63         226/211                 \-                    92.5 ± 8.7                  92.5 ± 3.7
  Benzophenone-4                             75.0     1.90         306/291                 306/211               103.0 ± 5.5                 100.5 ± 2.4
  **Illicit drugs**                                                                                                                          
  Amphetamine                                42.9     1.76         136/119                 136/91                101.0 ± 9.3                 105.3 ± 6.7
  Methamphetamine                            28.6     1.28         150/119                 150/91                109.6 ± 4.1                 106.3 ± 3.3
  Cocaine                                    0        1.25         304/182                 304/82                103.4 ± 4.5                 104.2 ± 2.2
  Heroin                                     0        1.41         370/268                 370/210               102.8 ± 6.4                 109.4 ± 5.0
  Ketamine                                   85.7     2.50         238/219                 238/125               105.3 ± 4.1                 97.6 ± 7.5
  Pseudoephedrine                            100      0.45         166/148                 166/133               91.5 ± 4.0                  97.7 ± 3.5
  Cannabinol                                 0        0.61         309/279                 309/171               96.7 ± 8.3                  97.4 ± 5.7
  Flunitrazepam                              0        0.81         314/267                 314/239               102.5 ± 8.5                 103.8 ± 5.3
  3,4-Methylenedioxymethamphetamine (MDMA)   0        0.52         194/163                 194/104               102.1 ± 5.2                 107.3 ± 6.5
  Gamma-Hydroxybutyric acid (GHB)            32.0     2.03         103/85                  103/57                97.2 ± 6.0                  109.0 ± 7.2

NSAIDs: non-steroidal anti-inflammatory drugs.

DF (%): Detection frequency.

Environmental risk assessment {#sec008}
-----------------------------

Levels of environmental risk from these ECs are evaluated based on methods described by several authors \[[@pone.0122813.ref024]--[@pone.0122813.ref027]\]. Risk quotients (RQs) for aquatic organisms were calculated from the measured environmental concentration (MEC), and the predicted no effect concentration (PNEC) of the EC compounds. In this study, the highest concentration measured in the river waters was used for maximum MEC to calculate the maximum RQs. PNEC is calculated by dividing the lowest chronic no observed effect concentration (NOEC) by the assessment factor according to the European Technical Guidance Document \[[@pone.0122813.ref028]\]. A commonly used risk ranking criteria was applied: RQs \<0.1 means minimal risk, 0.1≤ RQs \<1 means median risk, and RQs ≥1 means high risk \[[@pone.0122813.ref029]\].

Multivariate statistical analysis {#sec009}
---------------------------------

Hierarchical cluster analysis (HCA) is a statistical method to classify samples into clusters through their similarity and different cluster rules. In this work, the HCA was implemented in SPSS 16.0, using Ward's Hierarchical agglomerative method of clustering and Euclidean distance measure, to analyze the relationships among the chemical compounds. Source contribution analysis was conducted using principal component analysis-multiple linear regression (PCA-MLR) model. The purpose of PCA is to represent the total variability of the original EC data in a minimum number of factors. Each factor is orthogonal to all others, which results in the smallest possible covariance. The first factor represents the weighted (factor loadings) linear combination of the original variables (i.e., individual ECs) that account for the greatest variability. Each subsequent factor accounts for less variability than the previous factor. By critically evaluating the factor loadings, an estimate of the chemical source responsible for each factor can be made. The concentrations were Kaiser normalized and Varimax rotation was used as the preferred transformation. Multiple linear regression was than performed on the significant factors to determine the mass apportionment of each source to total concentrations. Stepwise modeling was used to allow each independent factor to enter into the regression equation if it could significantly increase the correlation, and a default significant level of 0.05 was used here. After normalization, the MLR equation can be expressed as [Eq 1](#pone.0122813.e001){ref-type="disp-formula"}. $${\hat{Z}}_{sum} = {\sum{B_{k}FS_{k}}}$$ Where ${\hat{Z}}_{sum}$ is the standard normalized deviate of the sum of the chemical concentrations, *B* ~*k*~ represents the regression coefficients, and *FS* ~*k*~ are factor scores calculated by the PCA analysis. The mean percentage contribution can be calculated by *B* ~*k*~/∑ *B* ~*k*~, and the contribution of each source *k* was estimated as [Eq 2](#pone.0122813.e003){ref-type="disp-formula"}.

![](pone.0122813.e003.jpg){#pone.0122813.e003g}
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More information of PCA-MLR in environmental studies can be found in the literatures \[[@pone.0122813.ref030],[@pone.0122813.ref031]\].

Results and Discussion {#sec010}
======================

Occurrence of ECs {#sec011}
-----------------

The results can be illustrated better by dividing the 28 ECs into 6 groups based on their general uses and/or origins: non-steroidal anti-inflammatory drugs (NSAIDs), illicit drugs, personal care products, antibiotics, caffeine, and other pharmaceuticals (clofibric acid, gemfibrozil, and carbamazepine). The high overall frequency of detection for ECs is likely influenced by the study design, which places a focus on sampling sites generally considered susceptible to contamination (i.e., downstream of intense population, levels of urbanization, and livestock production). A large proportion of the ECs (22 out of 28) are detected at least once ([Fig 2](#pone.0122813.g002){ref-type="fig"}). Among the 22 detected ECs, ibuprofen and pseudoephedrine were detected in 100% of samples ([S2 Table](#pone.0122813.s003){ref-type="supplementary-material"}). Measured concentrations are generally low (median detectable concentrations generally \< 1000 ng/L); the exception is caffeine (2792 ng/L), with a maximum concentration of 41,200 ng/L. Caffeine shows the highest concentration, with a high frequency of detection, which is not surprising, given its prevalence in beverages, foods, and pharmaceuticals \[[@pone.0122813.ref032]\]. Ibuprofen is detected in all surface water samples at concentrations ranging from 1.9 to 4000 ng/L. This observation is similar to findings reported in previous research \[[@pone.0122813.ref033],[@pone.0122813.ref034]\] and might be explained by the fact that ibuprofen is a commonly used antiphlogistic drug, with widespread use in the treatment of symptoms of colds, aches, and pains, and for treatment of arthritic conditions \[[@pone.0122813.ref025]\].

![Concentration ranges of emerging contaminants in the water systems in two sampling campaigns.\
The solid bar makes the median. The box denotes the 0.25 and 0.75 percentiles. The whiskers mark the last value within a range of 1.5 times the 0.25 and 0.75 percentiles. Outliers are marked by dots. The values at the x-axis show the detection frequency.](pone.0122813.g002){#pone.0122813.g002}

Concentration ranges of ECs found in this study are listed in [Table 3](#pone.0122813.t003){ref-type="table"}, which also summarizes those reported worldwide in the literatures \[[@pone.0122813.ref027],[@pone.0122813.ref035]--[@pone.0122813.ref053]\]. Concentrations detected in this study are generally comparable to those from rivers in Japan, Korea, China, India, UK, and Spain, but slightly lower than those reported in the US ([Table 3](#pone.0122813.t003){ref-type="table"}). Observed differences between data from Taiwan and data from other countries can be either site specific or due to general differences in prescribing patterns among countries. In addition, the possible explanation for this pattern in Taiwan may be due to the misuse of Taiwan's National Health Insurance (NHI) program. NHI program was launched in 1995, and the NHI coverage rate has now reached 99.6%. This program provides universal health coverage and its benefit package is comprehensive; all necessary medical services are covered. The package covers inpatient and outpatient services, dental work, traditional Chinese medicine, and provides access to nearly 20,000 prescription drugs \[[@pone.0122813.ref054]\]. Therefore, misuse of this system may lead to large amounts of unnecessary pharmaceutical distribution, increasing direct disposal of unused medicine, releasing it into the aquatic environment.

10.1371/journal.pone.0122813.t003

###### Comparison of EC concentrations in surface waters (ng/L) in the present study with those reported worldwide.

![](pone.0122813.t003){#pone.0122813.t003g}

  Compounds                          Asia         Europe                         America                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  ---------------------------------- ------------ ------------------------------ ----------------------------------------------------- --------------------------------------------------------------------------------------------------- ------------------------------ ----------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------------------------------ --------------------------------------- ---------------------------------------------------------- -----------------------------------------
  **Acetaminophen**                  BDL-323      BDL -185                       BDL -210                                              BDL                                                                                                 BDL -263                       BDL -73                                                                                                                                                                                    BDL -2382^\[[@pone.0122813.ref039]\]^   BDL -872^\[[@pone.0122813.ref041]\]^                       BDL -10000^\[[@pone.0122813.ref045]\]^
  **Diclofenac**                     BDL -16      BDL -350                       38--329                                               33--44                                                                                              BDL -220                       0.87--30^\[[@pone.0122813.ref036]\]^                  150^\[[@pone.0122813.ref027]\]^                                               BDL-26                                                 BDL -261^\[[@pone.0122813.ref039]\]^    BDL -148^\[[@pone.0122813.ref041]\]^                       BDL -177.1^\[[@pone.0122813.ref049]\]^
  **Ibuprofen**                      4.2--313     348--4000                      416--2606                                             102--816                                                                                            BDL -77                        1.2--51^\[[@pone.0122813.ref036]\]^                   685^\[[@pone.0122813.ref027]\]^                                               BDL-27                                                 BDL -100^\[[@pone.0122813.ref039]\]^    BDL -541^\[[@pone.0122813.ref041]\]^                       BDL -1000^\[[@pone.0122813.ref045]\]^
  **Ketoprofen**                     BDL -128     17--128                        89--341                                               290--371                                                                                            BDL -820                                                                             BDL-31^\[[@pone.0122813.ref050]\]^                                            BDL-16                                                 BDL -14^\[[@pone.0122813.ref039]\]^     BDL -1060^\[[@pone.0122813.ref041]\]^                      
  **Naproxen**                       BDL -19      11--210                        38--410                                               BDL -22                                                                                                                            5.3--100^\[[@pone.0122813.ref036]\]^                  125^\[[@pone.0122813.ref027]\]^                                               BDL-1.7                                                BDL -146^\[[@pone.0122813.ref039]\]^    BDL -109^\[[@pone.0122813.ref041]\]^                       BDL -135.2^\[[@pone.0122813.ref046]\]^
  **Salicylic acid**                 7.9--19      BDL -7.8                       BDL -5.2                                              BDL -8.4                                                                                                                                                                                 14736^\[[@pone.0122813.ref027]\]^                                                                                                    BDL -302^\[[@pone.0122813.ref039]\]^                                                               
  **Codeine**                        BDL -99      13--108                        64--137                                               42--100                                                                                                                                                                                                                                                                                                                       BDL -815^\[[@pone.0122813.ref039]\]^    BDL -52^\[[@pone.0122813.ref042]\]^                        BDL -1000^\[[@pone.0122813.ref045]\]^
  **Sulfamethoxazole**               BDL -322     16--324                        110--455                                              53--126                                                                                             BDL -160                       BDL -36^\[[@pone.0122813.ref037]\]^                   BDL -940^\[[@pone.0122813.ref038]\]^                                                                                                 BDL -4^\[[@pone.0122813.ref039]\]^                                                                 BDL -520^\[[@pone.0122813.ref045]\]^
  **Ampicillin**                     BDL -1684    BDL -428                       BDL -610                                              212--336                                                                                                                                                                                                                                                                                                                                                                                                                         
  **Tetracycline**                   BDL -72      12--112                        27--74                                                BDL -45                                                                                                                                                                                  BDL-320^\[[@pone.0122813.ref052]\]^                                                                                                                                                                                                     BDL -110^\[[@pone.0122813.ref045]\]^
  **Erythromycin-H** ~**2**~ **O**   BDL -20      4.0--126                       34--243                                               26--54                                                                                                                             BDL -4.8^\[[@pone.0122813.ref037]\]^                  BDL -121^\[[@pone.0122813.ref038]\]^                                                                                                 BDL -351^\[[@pone.0122813.ref039]\]^    BDL -4d2^\[[@pone.0122813.ref041]\]^                       BDL -1700^\[[@pone.0122813.ref045]\]^
  **Clofibric acid**                 BDL          BDL -11                        BDL -11                                               BDL -18                                                                                             BDL -110                                                                             18.3^\[[@pone.0122813.ref027]\]^                                                                                                     BDL -164^\[[@pone.0122813.ref039]\]^    BDL -6.1^\[[@pone.0122813.ref041]\]^                       3.2--26.7^\[[@pone.0122813.ref046]\]^
  **Gemfibrozil**                    BDL -61      BDL -904                       199--605                                              BDL -238                                                                                                                           0.25--13^\[[@pone.0122813.ref036]\]^                  31.2^\[[@pone.0122813.ref027]\]^                                                                                                                                             BDL -212^\[[@pone.0122813.ref041]\]^                       BDL -790^\[[@pone.0122813.ref045]\]^
  **Carbamazepine**                  BDL -14      22--359                        45--119                                               29--67                                                                                              BDL -86                        8.4--68^\[[@pone.0122813.ref036]\]^                   43.1^\[[@pone.0122813.ref027]\]^                                              BDL-5.4                                                BDL -684^\[[@pone.0122813.ref039]\]^    BDL -54^\[[@pone.0122813.ref041]\]^                        42.9--113.7^\[[@pone.0122813.ref046]\]^
  **Caffeine**                       BDL -1016    792--41200                     2792--26800                                           BDL -728                                                                                            BDL -3500                      38--250^\[[@pone.0122813.ref036]\]^                                                                                                                                                        437^\[[@pone.0122813.ref040]\]^                                                                    BDL -6000^\[[@pone.0122813.ref045]\]^
  **Benzophenone-3**                 BDL          BDL -6.4                       BDL -5.2                                              BDL                                                                                                                                                                                                                                                                                                                           BDL -44^\[[@pone.0122813.ref039]\]^     BDL-295^\[[@pone.0122813.ref051]\]^                        
  **Benzophenone-4**                 BDL -7.8     33--180                        7.2--90                                               BDL -41                                                                                                                                                                                                                                                                                                                       BDL -371^\[[@pone.0122813.ref039]\]^                                                               
  **Amphetamine**                    BDL          BDL -202                       3.7--47                                               BDL                                                                                                                                                                                                                                                                                                                           BDL -21^\[[@pone.0122813.ref039]\]^     BDL -3.4^\[[@pone.0122813.ref042]\]^                       BDL ^\[[@pone.0122813.ref048]\]^
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     BDL -4.3^\[[@pone.0122813.ref040]\]^    1.6--11.8^\[[@pone.0122813.ref043]\]^                      
  **Methamphetamine**                BDL          BDL -237                       BDL -122                                              BDL                                                                                                                                                                                                                                                                                                                           BDL ^\[[@pone.0122813.ref040]\]^        BDL -0.7^\[[@pone.0122813.ref044]\]^                       BDL -570^\[[@pone.0122813.ref047]\]^
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             0.3--0.7^\[[@pone.0122813.ref043]\]^                       BDL -62.6^\[[@pone.0122813.ref048]\]^
  **Cocaine**                        BDL          BDL                            BDL                                                   BDL                                                                                                                                                                                                                                                                                                                           14^\[[@pone.0122813.ref040]\]^          BDL -11.6^\[[@pone.0122813.ref043]\]^                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             BDL -59.2^\[[@pone.0122813.ref044]\]^                      
  **Heroin**                         BDL          BDL                            BDL                                                   BDL                                                                                                                                                                                                                                                                                                                           BDL ^\[[@pone.0122813.ref040]\]^        BDL ^\[[@pone.0122813.ref042]--[@pone.0122813.ref044]\]^   
  **Ketamine**                       BDL -77      180--3084                      BDL -195                                              BDL -125                                                                                                                                                                                                                                                                                                                      51^\[[@pone.0122813.ref040]\]^          BDL -415^\[[@pone.0122813.ref042]\]^                       
  **Pseudoephedrine**                BDL -176     46--680                        38--821                                               58--112                                                                                                                                                                                                                                                                                                                       BDL -16.5^\[[@pone.0122813.ref040]\]^   0.7--145^\[[@pone.0122813.ref043]\]^                       BDL -3300^\[[@pone.0122813.ref047]\]^
  **MDMA**                           BDL          BDL                            BDL                                                   BDL                                                                                                                                                                                                                                                                                                                           BDL -24.8^\[[@pone.0122813.ref040]\]^   BDL -3.4^\[[@pone.0122813.ref043]\]^                       BDL -96^\[[@pone.0122813.ref047]\]^
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             BDL -11.8^\[[@pone.0122813.ref044]\]^                      
  **GHB**                            BDL -25      BDL -4.2                       BDL                                                   BDL                                                                                                                                                                                                                                                                                                                                                                                                                              
  **References**                     This study   ^\[[@pone.0122813.ref035]\]^   ^\[[@pone.0122813.ref036],[@pone.0122813.ref037]\]^   ^\[[@pone.0122813.ref027],[@pone.0122813.ref038],[@pone.0122813.ref050],[@pone.0122813.ref052]\]^   ^\[[@pone.0122813.ref053]\]^   ^\[[@pone.0122813.ref039],[@pone.0122813.ref040]\]^   ^\[[@pone.0122813.ref041]--[@pone.0122813.ref044],[@pone.0122813.ref051]\]^   ^\[[@pone.0122813.ref045]--[@pone.0122813.ref049]\]^                                                                                                      

BDL: Below detection limit.

Patterns and signatures {#sec012}
-----------------------

Gaoping River is a characteristic mountain river, with a slender and sharp upstream basin. Most inhabitants (97.4%) are located in downstream areas \[[@pone.0122813.ref055]\]. Therefore, only scarce EC concentrations could be found at the stations G1-G4, reflecting background levels in the rural area ([Fig 3](#pone.0122813.g003){ref-type="fig"}). Ampicillin shows the highest concentrations of antibiotics (1920 ng/L) in Gaoping River. Animal husbandry, such as pig farming, and inappropriate disposal of manure into watercourses might explain these high antibiotic concentrations. It is estimated that there are approximately 1.9 million pigs in the drainage area of Gaoping River, approximately 30% of the entire pig production of Taiwan \[[@pone.0122813.ref056]\]. Thus, it is expected that there is a pronounced signal from animal husbandry. On the other hand, Ning et al. \[[@pone.0122813.ref057]\] find that livestock such as pig farming can be a potential threat for the water resources due to inappropriate disposal of manure into watercourses in the catchments of Gaoping River. This may represent a critical issue, as downstream waters are an important drinking water source for Kaohsiung city.

![Distribution of (a) antibiotics, NSAIDs, other pharmaceuticals (clofibric acid, carbamazepine, and gemfibrozil), personal care products, illicit drugs, and (b) caffeine in all samples of the water systems.](pone.0122813.g003){#pone.0122813.g003}

Relatively high EC concentrations were observed in upstream area of Love River. This may be so because two of the largest hospitals in Kaohsiung are located along Love River ([Fig 1](#pone.0122813.g001){ref-type="fig"}). Caffeine, NSAIDs, and illicit drugs have relatively high concentrations and frequencies of detection in Love River. It may reflect that cumulative contributions from domestic impact. As part of water quality management of Love River, two river interception stations were installed to collect and redirect river water for ocean outfall disposal. Hence, the downstream river waters are mainly composed of rainwater and tidal water from estuarine regions, where EC concentrations are relatively low. Higher concentrations found in Houjin River than in Dianbao River may be explained by the fact that Houjin River serves 4 times greater population in its catchment area than Dianbao River \[[@pone.0122813.ref055]\]. In addition, to a certain extent, Dianbao River demonstrates a similar compositional pattern with Gaoping River. The elevated concentration of antibiotics in Dianbao River may also be attributed to antibiotics use in the nearby animal husbandry area.

The signatures among various rivers could be demonstrated in the plot of EC concentrations for Human-ECs (human-use drugs, including NSAIDs, clofibric acid, carbamazepine, gemfibrozil, personal care products, and illicit drugs) and antibiotic concentrations ([Fig 4](#pone.0122813.g004){ref-type="fig"}). A distinct skewness between human-ECs and antibiotics is found in Gaoping River and Love River. Stations in Love River and Houjin River both contained much higher concentrations of Human-ECs than antibiotics, suggesting the dominant domestic impact. On the contrary, stations in Gaoping River only have elevated levels of antibiotics, indicating an observable impact from antibiotics application on animal husbandry. In addition, a much lower concentration is observed at stations in the upstream Gaoping River (G1-G4), reflecting a signature of rural area. The results are also in agreement with the discussion mentioned above.

![Human-EC concentrations versus antibiotic concentrations in two sampling campaigns in different water systems.\
Human-EC concentrations include the concentrations of NSAIDs, other pharmaceuticals (clofibric acid, carbamazepine, and gemfibrozil), personal care products, and illicit drugs. Antibiotic concentrations are the sum of sulfamethoxazole, ampicillin, tetracycline, and erythromycin-H2O concentrations.](pone.0122813.g004){#pone.0122813.g004}

Source contribution {#sec013}
-------------------

To further identify the source contribution based on the profiles of ECs, we performed for all samples principal component analysis followed by multiple linear regression (PCA-MLR) and hierarchical cluster analysis (HCA). Concentrations below the LOQs were recorded as half of the LOQ values in the datasheet. The compounds used for multivariate analysis are shown in [Table 4](#pone.0122813.t004){ref-type="table"}, and chemicals without detection or with low detection frequency were not included. PCA of the data sets in this study evolved three principal components (PCs) with eigenvalue \>1. These 3 PCs were identified after varimax rotation, which accounted for 30%, 18%, and 17% of the total variance, respectively. It may be due to the missing values and replaced by half of the LOQ values of EC contaminants giving low variation in the data. Thus, some PCs captured low variance in PCA analysis \[[@pone.0122813.ref058],[@pone.0122813.ref059]\]. The first component (PC1) is highly associated with diclofenac, ibuprofen, naproxen, ketoprofen, erythromycin-H~2~O, gemfibrozil, carbamazepine, caffeine, benzophenone-3, benzophenone-4, and pseudoephedrine, which are important chemicals in the human profile. Thus, PC1 could be highly indicative of the source due to domestic sewage discharging into the environment. The second component (PC2) is characterized by high loadings of sulfamethoxazole, ampicillin, tetracycline, and erythromycin-H~2~O. Chang et al. \[[@pone.0122813.ref060]\] investigated overall antibiotic consumption in both humans and animals in Taiwan. Annual consumption of human-use antibiotics is estimated at 329--378 tons, while 869--1,040 tons is estimated for animal-use antibiotics. This indicates that animal-use antibiotics account for 70%-76% of the total quantity of antibiotics consumed, suggesting that consumption of antibiotics in Taiwan is mainly for animal-use. Based on this profile, antibiotics application in animal husbandry area near those sites was speculated to be the potential source. The third component (PC3) has high loadings of amphetamine, methamphetamine, ketamine, and codeine and moderate loadings of ibuprofen and pseudoephedrine. Origins of these chemicals are mainly from drug abuse although some of them may partially use for medication in hospitals. Therefore, high proportions of these drugs in PC3 could also be further clarified by drug abuse.

10.1371/journal.pone.0122813.t004

###### PCA loadings of investigated ECs.

![](pone.0122813.t004){#pone.0122813.t004g}

  Total variance explained   PC1         PC2         PC3
  -------------------------- ----------- ----------- -----------
  Acetaminophen              0.202       0.106       0.070
  Diclofenac                 **0.847**   0.372       0.268
  Ibuprofen                  **0.656**   0.424       **0.575**
  Naproxen                   **0.922**   0.169       0.094
  Ketprofen                  **0.750**   0.142       -0.109
  Salicylic_acid             -0.253      -0.021      -0.209
  Codenie                    0.306       0.275       **0.766**
  Sulfamethoxazole           0.200       **0.854**   0.190
  Ampicillin                 -0.023      **0.744**   -0.077
  Tetracycline               0.211       **0.563**   0.329
  Erythromycin-H~2~O         **0.669**   **0.619**   0.168
  Clofibric_acid             0.023       0.008       -0.018
  Gemfibrozil                **0.917**   0.156       -0.049
  Carbamazepine              **0.791**   0.331       0.439
  Caffeine                   **0.802**   0.057       0.379
  Benzophenone-3             **0.555**   -0.128      0.255
  Benzophenone-4             **0.569**   -0.026      0.315
  Amphetamine                0.047       0.168       **0.932**
  Methamphetamine            0.166       0.098       **0.861**
  Ketamine                   0.186       -0.161      **0.782**
  Pseudoephedrine            **0.749**   0.033       **0.566**

Extraction Method: Principal Component Analysis.

Rotation Method: Varimax with Kaiser Normalization.

Multiple linear regression analysis with the factor score (FS~*k*~) against the standard normalized deviate of the sum concentrations of the 22 chemicals (${\hat{Z}}_{sum}$) was performed to determined the mass apportionment of the three components in all samples. The resulting equation was as follows: $${\hat{Z}}_{sum} = 0.807FS_{1} + 0.133FS_{2} + 0.430FS_{3}\left( {R^{2} = 0.963} \right)$$

By expanding ${\hat{Z}}_{sum}$ and rearranging terms, the MLR equation becomes: $$Z_{sum} = 0.807\sigma FS_{1} + 0.133\sigma FS_{2} + 0.430\sigma FS_{3} + mean\left\lbrack Z_{sum} \right\rbrack$$ Where *σ* was 7389 ng/L; and *mean*\[*Z* ~*sum*~\] was 5926 ng/L. Thus the mean percentage contribution (*B* ~*k*~/∑ *B* ~*k*~) was 58.9% for domestic impact (FS~1~), 9.7% for antibiotics application (FS~2~), and 31.4% for drug abuse (FS~3~). [Fig 5](#pone.0122813.g005){ref-type="fig"} shows the estimated contributions for each source in all samples in two sampling campaigns. The positive contributions explain the variations of the source contributions in all rivers, and the negative contributions indicate the outcome of improper variable scaling inherent in PCA methods as described previously \[[@pone.0122813.ref031]\]. The PCA-MLR analysis showed that contributions due to antibiotics application (FS~2~) were relatively low except for samples collected near animal husbandry area (Stations G6, G7, D2, D3, and D4); these data point to antibiotics application on animal husbandry as a significant source of antibiotics contamination. The contribution levels in Love River and Houjin River were high and showed substantial domestic impact (FS~1~). The source tentatively attributed to drug abuse (FS~3~) was a contributor to most Love River samples, particularly those sites in the upstream. [S1 Fig](#pone.0122813.s001){ref-type="supplementary-material"} showed the relative percentage of source contribution at each sampling site. Relatively high percentage of FS~2~ was observed in Gaoping River (1.3--65% in dry season and 2.0--94% in wet season) and Dianbao River (40--63% in dry season and 37--74% in wet season), while high percentage of FS~1~ and FS~3~ were found in Love River (12--94% and 3.4--82% in dry season; 42--78% and 20--55% in wet season). These results may be consistent with land-use structure: Love River and Houjin River mainly flow through the residential areas of Kaohsiung City. Therefore, significant source contributions from domestic impact and drug abuse could be found in both two sampling campaigns for Love River and Houjin River.

![Source contributions based on principal component analysis with multiple linear regression (PCA-MLR).\
FS~1~: domestic impact; FS~2~: antibiotics application; FS~3~: drug abuse.](pone.0122813.g005){#pone.0122813.g005}

The dendrogram of sampling points in two sampling campaigns obtained by HCA is shown in [Fig 6](#pone.0122813.g006){ref-type="fig"}. Two well-differentiated clusters were observed: (I) a cluster characterized by high compositional fractions of caffeine; and (II) a cluster characterized by high compositional fractions of ampicillin. Cluster I is the largest, formed by all stations in Love River and Houjin River and station D1 and D2. These results indicate that the signature in this cluster bears mainly domestic impacts. Cluster II comprises stations in Gaoping River and Dianbao River (G1-G8, D3, and D4). This cluster contained stations (G1-G4) with the lowest concentration of ECs, and stations characterized by high-level antibiotics. These results indicate that the signatures of cluster II were mainly derived from rural and animal husbandry contributions. These findings gave similar results and provided further evidence to source contributions.

![Hierarchical cluster analysis (HCA) of the water systems in two sampling campaigns, and the compositional patterns of ECs in representative clusters.\
The error bars represent one standard deviation of the concentrations of each compound of the relevant cluster.](pone.0122813.g006){#pone.0122813.g006}

Environmental risk characterization {#sec014}
-----------------------------------

Environmental risks to aquatic organisms are assessed for a worst case scenario in southern Taiwan based on the RQ calculated using maximum MECs and PNECs ([Table 5](#pone.0122813.t005){ref-type="table"}). Overall, ampicillin has the highest RQ, and the values in Gaoping River, Love River, Houjin River, and Dianbao River are 22.45, 5.71, 8.13, and 4.48, respectively. Both RQ values for ampicillin and codeine in the four rivers exceed 1.0, indicating their potential risk to aquatic organisms. Ibuprofen and diclofenac may pose a high risk to aquatic organisms in Love River and Houjin River. Similar results for these ECs with high risk are also found in surface waters worldwide. Hernando et al. \[[@pone.0122813.ref029]\] predict high risk levels based on the RQ values of ibuprofen, diclofenac, ketoprofen, gemfibrozil, erythromycin-H~2~O, clofibric acid, and carbamazepine in surface water and STP effluent in Europe. RQ values greater than 1.0 have been reported for ibuprofen in the Danish aquatic environment and in Spanish sewage effluent \[[@pone.0122813.ref061],[@pone.0122813.ref062]\], as well as for diclofenac in a Norwegian river \[[@pone.0122813.ref063]\], Australian sewage effluent \[[@pone.0122813.ref064]\], and in the Pearl River, China \[[@pone.0122813.ref027]\]. In summary, risk assessment in the present study shows that ibuprofen, diclofenac, and codeine are the three NSAIDs with high ecological risk, whereas ampicillin and erythromycin-H~2~O are the two antibiotics with high ecological risk. Although direct acute ecological effects have not been reported in the aquatic environment, and the PNEC values were not derived for the most sensitive species in this study area, precautionary measures should be taken to reduce risks to aquatic organisms due to potential subtle chronic changes caused by ECs in southern Taiwan.

10.1371/journal.pone.0122813.t005

###### Maximum measured environmental concentrations (MECs), predicted no effect concentrations (PNECs), and risk quotients (RQs) of each EC.

![](pone.0122813.t005){#pone.0122813.t005g}

  Compounds            Maximum MEC (ng/L)           RQs (Maximum MEC/PNEC)                                                   
  -------------------- -------------------- ------- ------------------------ ----- ------- ---------- ---------- ----------- ----------
  Acetaminophen        323                  185     210                      BDL   9200    0.035      0.02       0.023       0
  Diclofenac           16                   350     329                      44    100     0.16       **3.5**    **3.29**    0.44
  Ibuprofen            313                  4000    2606                     816   2000    0.157      **2**      **1.303**   0.408
  Ketoprofen           128                  128     341                      371   15600   0.008      0.008      0.219       0.238
  Naproxen             19                   210     410                      22    20000   0.001      0.011      0.021       0.001
  Salicylic acid       19                   7.8     5.2                      8.4   60000   0.0003     0.0001     0.0001      0.0001
  Codeine              99                   108     137                      100   60      **1.65**   **1.8**    **2.28**    **1.67**
  Sulfamethoxazole     322                  324     455                      126   20000   0.0161     0.0162     0.0228      0.0063
  Ampicillin           1684                 428     610                      336   75      **22.5**   **5.71**   **8.13**    **4.48**
  Tetracycline         72                   112     74                       45    90      0.8        **1.24**   0.82        0.5
  Erythromycin-H~2~O   20                   126     243                      54    40      0.5        **3.15**   **6.08**    **1.35**
  Clofibric acid       BDL                  11      11                       18    1000    0          0.011      0.011       0.018
  Gemfibrozil          61                   904     605                      238   1000    0.061      0.904      0.605       0.238
  Carbamazepine        14                   359     119                      67    2500    0.0056     0.1436     0.0476      0.0268
  Caffeine             1016                 41200   26800                    728   10^7^   0.0001     0.0041     0.0027      0.0001
  Benzophenone-3       BDL                  6.4     5.2                      BDL   3900    0          0.0016     0.0013      0
  Benzophenone-4       7.8                  180     90                       41    4897    0.0015     0.0368     0.0184      0.0083

BDL: Below detection limit.

Limitation, advantage and application {#sec015}
-------------------------------------

One important limitation of developing this pharmaco-signature is the selection of the most representative and indicative target compounds. For example, several EC compounds have different applications and may be used for both human and veterinary treatment, and therefore, no distinct pattern could be observed. The use of ECs may also vary among countries. Thus, the greater difficulty lies in proper source identification. It is important for researchers that should strive to include key EC source markers that will improve the ability to identify the pharmaco-signature from this concept.

Despite the limitations, this methodology revealed several advantages. In the step-by-step approach, the first step is determining concentration distribution in terms of individual ECs, species groups, and percentages to summed EC concentrations, which can then be used to identify abundant chemicals and to clarify patterns and signatures. The second step is implementing PCA-MLR method to resolve predominant factors and source contributions. The third step is using HCA method to obtain differentiated clusters. PCA-MLR or HCA method alone cannot clearly characterize EC sources. Performing both of these methods enable to confirm and support each other and can clarify the potential source contributions.

In this study, PCA-MLR and HCA analysis were used to identify source contribution and to clarify patterns and signatures by comparing two sampling seasons despite those sampling campaigns were 3 years apart. The study showed that both PCA-MLR and HCA analysis gave similar results of pharmaco-signature in those sampling campaigns, indicating the universally coincident land-use in multi-scape water systems. Therefore, these results can strengthen the belief in the validity of these multivariate statistical analysis approaches in our study area in clarifying the potential source contributions.

The results of this concept have much broader implications for discerning source contributions. Where appropriate contaminant data are available, use of the developed methodology, with some additional perspectives geographical/hydrological characteristics of the study area, water quality parameter (e.g. BOD, TOC, *E*. *coli*), and chemical markers (e.g. pesticides, VOCs), makes it more applicable for environmental studies to further resolve potential source contributions and identification.

Supporting Information {#sec016}
======================

###### Relative percentage of source contributions based on principal component analysis with multiple linear regression (PCA-MLR).

FS~1~: domestic impact; FS~2~: antibiotics application; FS~3~: drug abuse.
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###### CAS number, formula, molecular weight, logK~ow~, logK~oc~, melting point, vapor pressure, and solubility of the selected ECs.
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###### The Rank of ECs according to the frequency of detection in the study area.

(DOCX)
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Click here for additional data file.

###### Materials and Methods.

Detailed descriptions of chemicals and standards, LC-MS/MS analysis, and environmental risk assessment in this study were provided in the S1 Text.
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Click here for additional data file.
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